Updates

Author Details

Joe Pierce

July 8, 2020July 8, 2020
Foundation Offers Free Online Memory Screenings

To promote brain health, the Alzheimer’s Foundation of America (AFA) is offering free online memory screenings that people can participate in from home. The ... Read more
July 6, 2020July 2, 2020
Caregiving Is a Judgment-free Zone

Caring for a person with Alzheimer’s disease is challenging enough without caustic, inaccurate criticisms leveled against the caregiver. Sadly, it happens, and what’s even ... Read more
July 6, 2020July 6, 2020
AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

AlzeCure Pharma announced positive results from its first clinical study of ACD856 for the potential treatment of Alzheimer’s disease. According to the company, ACD856 ... Read more
July 1, 2020July 1, 2020
Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

Amylyx Pharmaceuticals announced it has completed enrollment for the Phase 2 clinical trial of AMX0035 for treating Alzheimer’s disease. The placebo-controlled trial, PEGASUS (NCT03533257), will evaluate ... Read more
June 29, 2020June 25, 2020
Simple Solutions to Everyday Caregiving Challenges

Little annoyances often are the most frustrating for caregivers. Well, perhaps they’re not the most frustrating, but those small irritants certainly do rank right ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Author Details

Joe Pierce

Thanks! Please check your email for a confirmation email.

November 8, 2017November 8, 2017

Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment

News

Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more

Foundation Offers Free Online Memory Screenings

Caregiving Is a Judgment-free Zone

AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

Simple Solutions to Everyday Caregiving Challenges

Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy

Advanced Imaging Captures Protein Clumps in Neurons at Early Alzheimer Stages

Father’s Day Prompts Memories of My Mom’s Dementia Diagnosis

Amyloid Clumps Formed on Space Station Affected by Microgravity

Anavex 2-73 Trial for Early Alzheimer’s Expanded to Canada, UK

Let’s Use Alzheimer’s and Brain Awareness Month to Eliminate Brain Freeze

Subscribe to our mailing list

Neurotrope Launches Long-term Trial of Bryostatin-1

Alzheimer’s Disease: A Defense in Scary Times

‘The Longest Day’ Global Fundraiser Set for June 20

Mouth Bacteria Can Infect Brain Cells, Research Finds, Supporting Alzheimer’s Link

Helpful Steps Following a Dementia Diagnosis

FDA Approves Tauvid as First Tau Protein Tracer Tool for Alzheimer’s Diagnosis

Visiting a Loved One with Dementia Requires a Delicate Balance

PTI-125 Fails to Lower Alzheimer’s Protein Levels in Phase 2 Trial

Maintaining Brain Health Is Important for Future Cognitive Function

Potential Agitation Treatment, AXS-05, Shows Efficacy and Safety in Phase 2/3 Trial

Large Study Finds No Evidence That Low-dose Aspirin Reduces Alzheimer’s Risk

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Alzheimer’s Caregivers Often Fear Contracting the Disease

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

FDA Filing of Alzheimer’s Therapy Aducanumab Delayed to Late 2020, Biogen Says

Anticipating Summer Solstice in Support of Alzheimer’s Funding

Lundbeck Sharing Data on Failed Idalopirdine Trials with Scientists via C-Path

Let’s Celebrate Togetherness While Flattening the Curve

Phase 2/3 Trial of Treatment for Agitation in Alzheimer’s to Conclude Early

More Telemedicine Is a Good Thing

At-home Activities Offered for Alzheimer’s Patients During COVID-19 Pandemic

Trial of Oral Anavex 2-73 in Early Alzheimer’s to Continue with Adjustments

Carrying On, with Empathy

Blood Pressure Treatment May Aid Cognition in Very Early Alzheimer’s

Moderate Drinking Linked to Lower Amyloid-Beta Levels, Study Says

Caregivers Are Battling on All Fronts to Shield Loved Ones from Pandemic

Taking Dantrium via Nose More Effective than by Mouth, Lowers Dose, Study Suggests

Half of Primary Physicians Say U.S. is Unprepared for Growing Alzheimer’s Demands

Amino Acid L-Serine May Reduce Memory Loss in Alzheimer’s Disease, Study Suggests

PSEN1 Gene Alteration May Be Early Biomarker for Alzheimer’s, Study Suggests

How Caregivers Can Protect Their Loved Ones from Coronavirus

Pin It on Pinterest